26 "inflammatory bowel diseases" clinical trials found.
-
IBD Qorus: Improving the Quality of Care for Adults with Inflammatory Bowel Disease (IBD)
The IBD Qorus Program focuses on developing a patient and provider learning health system that will support the testing of strategies to improve care for ... -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence with Inflammatory Bowel DiSease Therapy ASSIST Study
The proposed study is a multicenter, randomized, controlled, clinical trial to be conducted over 12 months. Participants in the intervention arm will verify medication adherence ... -
Treat-to-Target of Endoscopic Remission in Patients with IBD in Symptomatic Remission
The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to ... -
Screening Assessment of Overlap Spondyloarthritis in Patients with Inflammatory Bowel Disease
Despite the known prevalence of SpA in patients with IBD, a formalized screening and disease activity monitoring strategy is not routine standard of care. This ... -
Sarcopenia as a Risk Factor for Adverse Postoperative Outcomes in IBD
We will conduct a prospective cohort study of 120 patients at NYU Langone. Patients who have a biopsy confirmed diagnosis of IBD, who are = 18 ... -
Corevitas Inflammatory Bowel Disease (IBD) Registry
The primary objective for this registry is to prospectively study the natural history of IBD, the prevalence and incidence of comorbidities, and targeted adverse events ... -
A Phase 2a Multicenter Randomized Platform Study of Targeted Therapies for the Treatment of Adult Subjects with Moderate to Severe Crohn's Disease
The purpose of this study is to evaluate the safety and efficacy of using multiple investigational medicines compared to a single medicine in subjects with ... -
A Phase 3 Randomized Double-Blind Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn s Disease
This trial is testing an experimental drug tulisokibart (MK-7240) in people with moderately to severely active Crohn’s disease (CD). This trial will compare tulisokibart ... -
ICONIC-CD Protocol 77242113CRD3001: A Phase 2b/3 Randomized Double-blind Placebo-Controlled Parallel Group Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
The purpose of this research study is to help researchers understand more about the possible effectiveness and safety of icotrokinra in patients with moderately to ... -
EFC18326 - A multicenter multinational randomized double-blind placebo-controlled Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn s Disease
The purpose of this research study is to study an experimental drug SAR447189, also called duvakitug, for the treatment of moderate to severe Crohn’s ...